Supplemental material
Human Vaccines & Immunotherapeutics
Volume 18, 2022 - Issue 5
Vaccine Safety – Research Paper
Kawasaki disease following immunization reported to the Canadian Immunization Monitoring Program ACTive (IMPACT) from 2013 to 2018
, , , 
, , , , , , , & for the IMPACT Investigators show allThe IMPACT project group, , MD, , MD, , MD, , MD, , MD, , MD, , MD, , MD, , MD, , MD, , MD, , MD, , MD, , MD, , MD, , MD, , MD, , MD, , MD, , BM BCh DPhil, , MD & , MD show all
Julie A. Bettingerb Vaccine Evaluation Center, BC Children’s Hospital Research Institute, Vancouver, BC, Canada;c Division of Infectious Diseases, Department of Pediatrics, British Columbia Children’s Hospital, Vancouver, BC, Canadahttps://orcid.org/0000-0002-2118-4174View further author information
https://orcid.org/0000-0002-2118-4174View further author information, , , , , Manish Sadaranganib Vaccine Evaluation Center, BC Children’s Hospital Research Institute, Vancouver, BC, Canada;c Division of Infectious Diseases, Department of Pediatrics, British Columbia Children’s Hospital, Vancouver, BC, Canadahttps://orcid.org/0000-0002-9985-6452View further author information
https://orcid.org/0000-0002-9985-6452View further author information, Scott A. Halperinf Department of Pediatrics, Dalhousie University, and Canadian Center for Vaccinology, IWK Health, Halifax, NS, Canadahttps://orcid.org/0000-0003-0525-589XView further author information
https://orcid.org/0000-0003-0525-589XView further author information, Karina A. Topf Department of Pediatrics, Dalhousie University, and Canadian Center for Vaccinology, IWK Health, Halifax, NS, CanadaCorrespondence[email protected]
https://orcid.org/0000-0002-9981-368XView further author information
https://orcid.org/0000-0002-9981-368XView further author information & for the IMPACT Investigators show allThe IMPACT project group, , MD, , MD, , MD, , MD, , MD, , MD, , MD, , MD, , MD, , MD, , MD, , MD, , MD, , MD, , MD, , MD, , MD, , MD, , MD, , BM BCh DPhil, , MD & , MD show all